Neuron
Volume 67, Issue 5, 9 September 2010, Pages 769-780
Journal home page for Neuron

Article
Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease

https://doi.org/10.1016/j.neuron.2010.08.018Get rights and content
Under an Elsevier user license
open archive

Summary

Alzheimer's disease (AD) is characterized pathologically by the abundance of senile plaques and neurofibrillary tangles in the brain. We synthesized over 1200 novel gamma-secretase modulator (GSM) compounds that reduced Aβ42 levels without inhibiting epsilon-site cleavage of APP and Notch, the generation of the APP and Notch intracellular domains, respectively. These compounds also reduced Aβ40 levels while concomitantly elevating levels of Aβ38 and Aβ37. Immobilization of a potent GSM onto an agarose matrix quantitatively recovered Pen-2 and to a lesser degree PS-1 NTFs from cellular extracts. Moreover, oral administration (once daily) of another potent GSM to Tg 2576 transgenic AD mice displayed dose-responsive lowering of plasma and brain Aβ42; chronic daily administration led to significant reductions in both diffuse and neuritic plaques. These effects were observed in the absence of Notch-related changes (e.g., intestinal proliferation of goblet cells), which are commonly associated with repeated exposure to functional gamma-secretase inhibitors (GSIs).

Highlights

► Over 1200 novel and potent gamma-secretase modulators were synthesized and tested ► Potent 2-aminothiazole GSMs decreased Aβ42 and Aβ40 and increased Aβ38 and Aβ37 ► A potent immobilized GSM derivative quantitatively recovered Pen-2 ► Potent GSM compounds did not inhibit epsilon cleavages of either APP, Notch, or E-cad

Cited by (0)

6

These authors contributed equally to this work

7

Present address: Neurogenetic Pharmaceuticals, Inc., San Diego, CA 92121, USA

8

Present address: Helicon Therapeutics, Inc., San Diego, CA 92121, USA

9

Present address: CalciMedica, Inc., La Jolla, CA 92037, USA

10

Present address: Department of Neurosciences, University of California, San Diego, La Jolla, CA 92037, USA